United Therapeutics
Clinical trials sponsored by United Therapeutics, explained in plain language.
-
Pig kidney transplant trial offers hope for patients out of options
Disease control Recruiting nowThis study is testing the safety and effectiveness of transplanting a kidney from a genetically modified pig into people with end-stage kidney disease. It is for patients who are either not eligible for a standard human kidney transplant or are on the waiting list but are unlikel…
Phase: PHASE1, PHASE2 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New inhaled hope for slowing devastating lung scarring
Disease control Recruiting nowThis large, late-stage study is testing whether an inhaled medication called treprostinil can safely slow the progression of lung scarring (progressive pulmonary fibrosis) in adults. About 700 participants will use either the drug or a placebo inhaler four times a day for one yea…
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Pig kidney breakthrough offers hope for patients out of options
Disease control Recruiting nowThis study is testing a kidney from a genetically modified pig as a transplant for people with end-stage kidney disease who are on dialysis. It's for patients who are not eligible for a human kidney transplant or are unlikely to get one in time. The main goals are to see if the t…
Phase: PHASE1, PHASE2 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New hunt for hidden Heart-Lung danger in scarred lungs
Diagnosis Recruiting nowThis study aims to find the best combination of tests to spot pulmonary hypertension (high blood pressure in the lungs) earlier in people who have interstitial lung disease (scarring of the lungs). Researchers will gather detailed health information from 300 participants through …
Sponsor: United Therapeutics • Aim: Diagnosis
Last updated Mar 24, 2026 12:01 UTC
-
Massive 1000-Patient study launches to map rare lung disease journey
Knowledge-focused Recruiting nowThis study aims to better understand a serious condition where high blood pressure develops in the lungs due to underlying lung scarring. Researchers will follow 1,000 patients for up to 5 years to track their health, treatments, and quality of life. The goal is to gather real-wo…
Sponsor: United Therapeutics • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC